
浏览全部资源
扫码关注微信
重庆医科大学附属第一医院精神医学中心,重庆 400016
王余娜,Email:wyn22345678@163.com,研究方向:抑郁症与电休克。
况 利,Email:kuangli0308@163.com。
收稿:2024-09-14,
修回:2024-12-06,
录用:2024-12-11,
纸质出版:2025-01-28
移动端阅览
王余娜,杜宁,耿丹丹,等.电休克对青少年重度抑郁症BDNF和氧化应激因子的影响[J].重庆医科大学学报,2025,50(1):123-129.
Wang Yuna,Du Ning,Geng Dandan,et al.Effect of electroconvulsive therapy on brain-derived neurotrophic factor and oxidative stress factors in adolescents with major depressive disorder[J].Journal of Chongqing Medical University,2025,50(1):123-129.
王余娜,杜宁,耿丹丹,等.电休克对青少年重度抑郁症BDNF和氧化应激因子的影响[J].重庆医科大学学报,2025,50(1):123-129. DOI: 10.13406/j.cnki.cyxb.003720.
Wang Yuna,Du Ning,Geng Dandan,et al.Effect of electroconvulsive therapy on brain-derived neurotrophic factor and oxidative stress factors in adolescents with major depressive disorder[J].Journal of Chongqing Medical University,2025,50(1):123-129. DOI: 10.13406/j.cnki.cyxb.003720.
目的
2
为探究电休克(electroconvulsive therapy,ECT)治疗对重度抑郁症(major depressive disorder,MDD)青少年患者的疗效,进行MDD青少年患者电休克治疗期间氧化应激水平、血清脑源性神经营养因子(brain-derived neurotrophic factor,BDNF)和抑郁程度的相关性分析。
方法
2
选择2023年5月至2023年12月在重庆医科大学附属第一医院38例重度抑郁症青少年患者为回顾性分析试验组(MDD组),采用问卷招募20例健康儿童作对照组。电休克治疗前及治疗结束后,采集MDD组17项汉密尔顿抑郁量表(17-items Hamilton depression scale,HAMD-17)、心理弹性量表(connor-davidson resilience scale,CD-RISC)等量表评分,并检测超氧化物歧化酶(superoxide dismutase,SOD)、丙二醛(malondialdehyde,MDA)、BDNF水平。对照组仅采集血样和人口学数据。
结果
2
MDD组治疗前的SOD和BDNF低于对照组(
P
<
0.001),差异具有统计学意义。MDA高于对照组(
P
<
0.001)。经过电休克治疗后,MDD组SOD较治疗前增高(
P
<
0.001)、BDNF较治疗前增高(
P
<
0.001),MDA较治疗前降低(
P
<
0.001),SOD、MDA、BDNF治疗后与治疗前比较差异均有统计学意义。HAMD-17治疗后降低(
P
<
0.001)、PDQ-D治疗后降低(
P
=0.004)、CFQ量表评分治疗后降低(
P
=0.001),评分差异有统计学意义;CD-RISC、AAQ-2量表评分治疗前后无统计学意义。相关性分析显示电休克治疗前后的SOD、MDA、BDNF分别和治疗前后HAMD-17评分存在弱相关性。多元逻辑回归分析显示电休克治疗前SOD水平能作为ECT治疗应答的独立影响因素,治疗前MDA、BDNF水平对HAMD-17治疗后评分差异无统计学意义。
结论
2
ECT治疗后,患者血清中SOD和BDNF升高、MDA降低。MDA降低,SOD和BDNF的增加与抑郁改善程度具有弱相关性,推测ECT治疗可改善MDD青少年患者抑郁症状,具体机制与SOD、MDA、BDNF改变有关,但3种指标能否成为预测电休克改善抑郁症状的独立影响因素还需进一步研究。
Objective
2
To investigate the effect of electroconvulsive therapy (ECT) on adolescents with major depressive disorder (MDD),as well as the correlation of oxidative stress and brain-derived neurotrophic factor (BDNF) with the degree of depression in adolescents with MDD during ECT.
Methods
2
A total of 38 adolescents with MDD from May to December 2023 were enrolled as retrospective analysis group(MDD group),and 20 healthy children were recruited as control group through a questionnaire survey. Before and after ECT,the scores of 17-item Hamilton Depression Rating Scale(HAMD-17) and Connor-Davidson Resilience Scale(CD-RISC) were collected from the adolescents in the experimental group,and the serum levels of superoxide dismutase(SOD),malondialdehyde(MDA),and BDNF were measured. Only blood samples and demographic data were collected for the control group.
Results
2
Compared with the control group,the MDD group had significantly lower levels of SOD and BDNF(
P
<
0.001) and a significantly higher level of MDA(
P
<
0.001) before treatment. After ECT,the MDD group had significant increases in SOD and BDNF(
P
<
0.001) and a significant reduction in MDA(
P
<
0.001). After treatment,there were significant reductions in the scores of HAMD-17(
P
<
0.001),PDQ-D(
P
=0.004),and CFQ(
P
=0.001),while there were no significant changes in the scores of CD-RISC and AAQ-2 after treatment. The correlation analysis showed that SOD,MDA,and BDNF were weakly correlated with HAMD-17 score before and after ECT. The multivariate logistic regression analysis showed that SOD level before ECT was an independent influencing factor for treatment response to ECT,while the levels of MDA and BDNF before treatment had no statistical significance on HAMD-17 score after treatment.
Conclusion
2
There are increases in the serum levels of SOD and BDNF and a reduction in the serum level of MDA after ECT. The reduction in MDA and the increases in SOD and BDNF have a weak correlation with the degree of improvement in depression,and it is speculated that ECT can improve depressive symptoms in adolescents with MDD,which is associated with the changes in SOD,MDA,and BDNF. However,further studies are needed to investigate whether these three indicators can be used as independent influencing factors to predict the improvement in depressive symptoms by ECT.
Otte C , Gold SM , Penninx BW , et al . Major depressive disorder [J ] . Nat Rev Dis Primers , 2016 , 2 : 16065 .
Kessler RC , Bromet EJ . The epidemiology of depression across cultures [J ] . Annu Rev Public Health , 2013 , 34 : 119 - 138 .
Li KW , Yan L , Zhang YP , et al . Seahorse treatment improves depression-like behavior in mice exposed to CUMS through reducing inflammation/oxidants and restoring neurotransmitter and neurotrophin function [J ] . J Ethnopharmacol , 2020 , 250 : 112487 .
Bahnson ES , Koo N , Cantu-Medellin N , et al . Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential,cell-specific modulation of SOD-1 in the arterial wall [J ] . Nitric Oxide , 2015 , 44 : 8 - 17 .
Li LL , Tan J , Miao YY , et al . ROS and autophagy:interactions and molecular regulatory mechanisms [J ] . Cell Mol Neurobiol , 2015 , 35 ( 5 ): 615 - 621 .
Björkholm C , Monteggia LM . BDNF - a key transducer of antidepressant effects [J ] . Neuropharmacology , 2016 , 102 : 72 - 79 .
Sengul MC , Kenar AN , Hanci E , et al . Practice of acute and maintenance electroconvulsive therapy in the psychiatric clinic of a university hospital from Turkey:between 2007 and 2013 [J ] . Clin Psychopharmacol Neurosci , 2016 , 14 ( 1 ): 57 - 63 .
Karege F , Perret G , Bondolfi G , et al . Decreased serum brain-derived neurotrophic factor levels in major depressed patients [J ] . Psychiatry Res , 2002 , 109 ( 2 ): 143 - 148 .
Kim YK , Lee HP , Won SD , et al . Low plasma BDNF is associated with suicidal behavior in major depression [J ] . Prog Neuropsychopharmacol Biol Psychiatry , 2007 , 31 ( 1 ): 78 - 85 .
Polyakova M , Schroeter ML , Elzinga BM , et al . Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy:systematic review and meta-analyses of the preclinical and clinical literature [J ] . PLoS One , 2015 , 10 ( 11 ): e0141564 .
Maffioletti E , Gennarelli M , Gainelli G , et al . BDNF genotype and baseline serum levels in relation to electroconvulsive therapy effectiveness in treatment-resistant depressed patients [J ] . J ECT , 2019 , 35 ( 3 ): 189 - 194 .
Sun Y , Zhong YW , Sun WZ , et al . More prevalent and more severe:gender differences of depressive symptoms in Chinese adolescents [J ] . Front Public Health , 2023 , 11 : 1167234 .
Wartberg L , Kriston L , Thomasius R . Depressive symptoms in adolescents [J ] . Dtsch Arztebl Int , 2018 , 115 ( 33/34 ): 549 - 555 .
Nuninga JO , Claessens TFI , Somers M , et al . Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder [J ] . J Affect Disord , 2018 , 238 : 659 - 665 .
Zupan G , Pilipović K , Hrelja A , et al . Oxidative stress parameters in different rat brain structures after electroconvulsive shock-induced seizures [J ] . Prog Neuropsychopharmacol Biol Psychiatry , 2008 , 32 ( 3 ): 771 - 777 .
Camkurt MA , Fındıklı E , İzci F , et al . Evaluation of malondialdehyde,superoxide dismutase and catalase activity and their diagnostic value in drug naïve,first episode,non-smoker major depression patients and healthy controls [J ] . Psychiatry Res , 2016 , 238 : 81 - 85 .
Barichello T , Bonatto F , Feier G , et al . No evidence for oxidative damage in the hippocampus after acute and chronic electroshock in rats [J ] . Brain Res , 2004 , 1014 ( 1/2 ): 177 - 183 .
Feier G , Jornada LK , Barichello T , et al . Long lasting effects of electroconvulsive seizures on brain oxidative parameters [J ] . Neurochem Res , 2006 , 31 ( 5 ): 665 - 670 .
Pardridge WM , Kang YS , Buciak JL . Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery [J ] . Pharm Res , 1994 , 11 ( 5 ): 738 - 746 .
Pan W , Banks WA , Fasold MB , et al . Transport of brain-derived neurotrophic factor across the blood-brain barrier [J ] . Neuropharmacology , 1998 , 37 ( 12 ): 1553 - 1561 .
Pillai A , Kale A , Joshi S , et al . Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects:correlation with plasma BDNF and psychopathology [J ] . Int J Neuropsychopharmacol , 2010 , 13 ( 4 ): 535 - 539 .
Bocchio-Chiavetto L , Zanardini R , Bortolomasi M , et al . Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients [J ] . Eur Neuropsychopharmacol , 2006 , 16 ( 8 ): 620 - 624 .
Olugbemide AS , Ben-Azu B , Bakre AG , et al . Naringenin improves depressive- and anxiety-like behaviors in mice exposed to repeated hypoxic stress through modulation of oxido-inflammatory mediators and NF-kB/BDNF expressions [J ] . Brain Res Bull , 2021 , 169 : 214 - 227 .
Selek S , Savas HA , Gergerlioglu HS , et al . The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode [J ] . J Affect Disord , 2008 , 107 ( 1/2/3 ): 89 - 94 .
Lv QY , Hu QY , Zhang WZ , et al . Disturbance of oxidative stress parameters in treatment-resistant bipolar disorder and their association with electroconvulsive therapy response [J ] . Int J Neuropsychopharmacol , 2020 , 23 ( 4 ): 207 - 216 .
0
浏览量
6
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621